adamantane has been researched along with Androgen-Independent Prostatic Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drake, RR; Garrett-Mayer, E; Jones, EE; Kraveka, JM; Lilly, MB; Lu, P; Rahmaniyan, M; Smith, CD; Venant, H; Voelkel-Johnson, C | 1 |
| McNaughton, M; Pitman, M; Pitson, SM; Pyne, NJ; Pyne, S | 1 |
2 other study(ies) available for adamantane and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.
Topics: Adamantane; Animals; Apoptosis; Cell Proliferation; Ceramides; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Oxidoreductases; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Pyridines; Xenograft Model Antitumor Assays | 2015 |
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
Topics: Adamantane; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Humans; Male; Oxidoreductases; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms, Castration-Resistant; Proteasome Endopeptidase Complex; Pyridines; Thiazoles | 2016 |